A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Abroad (travel likely)RecruitingPHASE1

Conditions

Polycythemia Vera (PV) · Myelofibrosis (MF) · Myeloproliferative Neoplasms (MPNs) · Post-Polycythemia Vera Myelofibrosis · Post-Essential Thrombocythemia Myelofibrosis · Primary Myelofibrosis (PMF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Colorado Blood Cancer Institute, Denver, Colorado, United States
BRCR Global - Coral Springs, Coral Springs, Florida, United States
START Midwest, LLC, Grand Rapids, Michigan, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office, Philadelphia, Pennsylvania, United States
Tristar BMT, Nashville, Tennessee, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Polycythemia Vera · ET (Essential Thrombocythemia) · Polycythemia Vera (PV)

Abroad (travel likely)Recruiting

Chicago, United States · New York, United States

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

Abroad (travel likely)RecruitingPHASE1

Kamogawa, Japan · Sapporo, Japan

Efficacy and Safety of Peginterferon in ET and PV.

Essential Thrombocythemia · Polycythemia Vera

Abroad (travel likely)Recruiting

Wuhan, China

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

Polycythemia Vera

Abroad (travel likely)Recruiting

Bergamo, Italy · Milan, Italy